CL logo

Colgate-Palmolive (CL) EBITDA

annual EBITDA:

$4.85B+$607.00M(+14.30%)
December 31, 2024

Summary

  • As of today (May 29, 2025), CL annual EBITDA is $4.85 billion, with the most recent change of +$607.00 million (+14.30%) on December 31, 2024.
  • During the last 3 years, CL annual EBITDA has risen by +$1.09 billion (+29.07%).
  • CL annual EBITDA is now at all-time high.

Performance

CL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

quarterly EBITDA:

$1.17B-$24.00M(-2.02%)
March 31, 2025

Summary

  • As of today (May 29, 2025), CL quarterly EBITDA is $1.17 billion, with the most recent change of -$24.00 million (-2.02%) on March 31, 2025.
  • Over the past year, CL quarterly EBITDA has dropped by -$23.00 million (-1.93%).
  • CL quarterly EBITDA is now -18.79% below its all-time high of $1.44 billion, reached on June 30, 1987.

Performance

CL quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

TTM EBITDA:

$4.82B-$23.00M(-0.47%)
March 31, 2025

Summary

  • As of today (May 29, 2025), CL TTM EBITDA is $4.82 billion, with the most recent change of -$23.00 million (-0.47%) on March 31, 2025.
  • Over the past year, CL TTM EBITDA has increased by +$423.00 million (+9.62%).
  • CL TTM EBITDA is now -0.47% below its all-time high of $4.84 billion, reached on December 31, 2024.

Performance

CL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.3%-1.9%+9.6%
3 y3 years+29.1%+16.9%+33.3%
5 y5 years+21.0%+7.6%+17.9%

CL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.9%-6.6%+330.6%-0.5%+43.0%
5 y5-yearat high+43.9%-6.6%+330.6%-0.5%+43.0%
alltimeall timeat high+1290.5%-18.8%+130.7%-0.5%+1027.1%

CL EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.17B(-2.0%)
$4.82B(-0.5%)
Dec 2024
$4.85B(+14.3%)
$1.19B(-2.0%)
$4.84B(+6.0%)
Sep 2024
-
$1.22B(-2.7%)
$4.57B(+0.9%)
Jun 2024
-
$1.25B(+5.0%)
$4.53B(+3.0%)
Mar 2024
-
$1.19B(+29.8%)
$4.40B(+3.6%)
Dec 2023
$4.25B(+25.9%)
$917.00M(-21.8%)
$4.25B(+17.9%)
Sep 2023
-
$1.17B(+4.8%)
$3.60B(+2.6%)
Jun 2023
-
$1.12B(+7.9%)
$3.51B(+2.8%)
Mar 2023
-
$1.04B(+282.7%)
$3.41B(+1.2%)
Dec 2022
$3.37B(-10.3%)
$271.00M(-74.9%)
$3.37B(-3.1%)
Sep 2022
-
$1.08B(+5.8%)
$3.48B(-0.7%)
Jun 2022
-
$1.02B(+2.4%)
$3.51B(-3.1%)
Mar 2022
-
$998.00M(+163.3%)
$3.62B(-3.8%)
Dec 2021
$3.76B(-13.9%)
$379.00M(-65.8%)
$3.76B(-15.2%)
Sep 2021
-
$1.11B(-2.3%)
$4.43B(-1.0%)
Jun 2021
-
$1.13B(-0.7%)
$4.48B(+1.2%)
Mar 2021
-
$1.14B(+8.4%)
$4.42B(+1.3%)
Dec 2020
$4.37B(+8.9%)
$1.05B(-8.6%)
$4.37B(+1.2%)
Sep 2020
-
$1.15B(+6.8%)
$4.32B(+4.0%)
Jun 2020
-
$1.08B(-0.6%)
$4.15B(+1.5%)
Mar 2020
-
$1.08B(+8.2%)
$4.09B(+1.9%)
Dec 2019
$4.01B(-3.7%)
$1.00B(+1.7%)
$4.01B(+0.6%)
Sep 2019
-
$986.00M(-3.0%)
$3.99B(-0.4%)
Jun 2019
-
$1.02B(+0.9%)
$4.00B(-1.5%)
Mar 2019
-
$1.01B(+2.8%)
$4.06B(-2.5%)
Dec 2018
$4.17B(+1.3%)
$980.00M(-2.1%)
$4.17B(-0.8%)
Sep 2018
-
$1.00B(-6.9%)
$4.20B(-2.0%)
Jun 2018
-
$1.07B(-3.3%)
$4.29B(+1.9%)
Mar 2018
-
$1.11B(+9.7%)
$4.21B(+2.2%)
Dec 2017
$4.12B(-5.0%)
$1.01B(-6.5%)
$4.12B(-2.5%)
Sep 2017
-
$1.08B(+9.0%)
$4.22B(-2.3%)
Jun 2017
-
$995.00M(-2.5%)
$4.32B(-1.3%)
Mar 2017
-
$1.02B(-8.8%)
$4.38B(+1.1%)
Dec 2016
$4.33B(+29.4%)
$1.12B(-5.6%)
$4.33B(+31.6%)
Sep 2016
-
$1.19B(+12.5%)
$3.29B(-1.9%)
Jun 2016
-
$1.05B(+8.2%)
$3.35B(+0.3%)
Mar 2016
-
$973.00M(+1116.3%)
$3.34B(-0.0%)
Dec 2015
$3.35B(-18.5%)
$80.00M(-93.6%)
$3.35B(-25.3%)
Sep 2015
-
$1.25B(+19.7%)
$4.48B(+4.3%)
Jun 2015
-
$1.04B(+7.1%)
$4.29B(-1.0%)
Mar 2015
-
$974.00M(-19.8%)
$4.34B(+5.7%)
Dec 2014
$4.11B(-0.4%)
$1.21B(+14.3%)
$4.11B(+2.2%)
Sep 2014
-
$1.06B(-2.3%)
$4.02B(-1.5%)
Jun 2014
-
$1.09B(+46.5%)
$4.08B(+1.7%)
Mar 2014
-
$742.00M(-34.2%)
$4.01B(-2.7%)
Dec 2013
$4.12B(-5.9%)
$1.13B(+0.3%)
$4.12B(+0.3%)
Sep 2013
-
$1.12B(+10.5%)
$4.11B(-0.2%)
Jun 2013
-
$1.02B(+19.4%)
$4.12B(-1.7%)
Mar 2013
-
$852.00M(-23.6%)
$4.19B(-4.4%)
Dec 2012
$4.38B(+2.6%)
$1.11B(-1.6%)
$4.38B(+1.9%)
Sep 2012
-
$1.13B(+4.2%)
$4.30B(-0.3%)
Jun 2012
-
$1.09B(+4.1%)
$4.31B(+0.4%)
Mar 2012
-
$1.04B(+0.9%)
$4.30B(+0.7%)
Dec 2011
$4.27B(+10.3%)
$1.03B(-9.8%)
$4.27B(+0.6%)
Sep 2011
-
$1.15B(+7.2%)
$4.24B(+2.3%)
Jun 2011
-
$1.07B(+5.6%)
$4.14B(+0.7%)
Mar 2011
-
$1.01B(+0.5%)
$4.12B(+6.3%)
Dec 2010
$3.87B(-2.7%)
$1.01B(-4.0%)
$3.87B(-2.1%)
Sep 2010
-
$1.05B(+1.0%)
$3.95B(+0.9%)
Jun 2010
-
$1.04B(+35.2%)
$3.92B(+1.7%)
Mar 2010
-
$770.00M(-29.4%)
$3.85B(-3.1%)
Dec 2009
$3.98B(+15.0%)
$1.09B(+7.4%)
$3.98B(+5.8%)
Sep 2009
-
$1.02B(+4.0%)
$3.76B(+3.8%)
Jun 2009
-
$977.00M(+9.4%)
$3.62B(+3.0%)
Mar 2009
-
$893.00M(+2.2%)
$3.52B(+1.7%)
Dec 2008
$3.46B(+13.7%)
$874.00M(-0.6%)
$3.46B(+1.6%)
Sep 2008
-
$879.60M(+0.8%)
$3.40B(+3.8%)
Jun 2008
-
$872.20M(+4.5%)
$3.28B(+4.3%)
Mar 2008
-
$834.30M(+1.9%)
$3.14B(+3.4%)
Dec 2007
$3.04B(+15.1%)
$818.70M(+8.6%)
$3.04B(-1.7%)
Sep 2007
-
$754.10M(+2.2%)
$3.09B(+4.2%)
Jun 2007
-
$737.70M(+0.8%)
$2.97B(+7.0%)
Mar 2007
-
$732.10M(-15.9%)
$2.78B(+5.1%)
Dec 2006
$2.64B(+0.7%)
$871.00M(+38.1%)
$2.64B(+5.2%)
Sep 2006
-
$630.50M(+16.1%)
$2.51B(-2.2%)
Jun 2006
-
$543.10M(-9.1%)
$2.57B(-3.0%)
Mar 2006
-
$597.70M(-19.2%)
$2.65B(+0.8%)
Dec 2005
$2.63B(+4.3%)
$739.70M(+7.7%)
$2.63B(+4.7%)
Sep 2005
-
$686.50M(+10.2%)
$2.51B(+2.8%)
Jun 2005
-
$623.10M(+8.2%)
$2.44B(-1.7%)
Mar 2005
-
$575.80M(-7.6%)
$2.48B(-1.4%)
Dec 2004
$2.52B
$623.00M(+0.6%)
$2.52B(-3.2%)
DateAnnualQuarterlyTTM
Sep 2004
-
$619.20M(-6.8%)
$2.60B(+0.3%)
Jun 2004
-
$664.60M(+8.7%)
$2.60B(+1.1%)
Mar 2004
-
$611.20M(-13.5%)
$2.57B(+1.0%)
Dec 2003
$2.54B(+10.0%)
$706.90M(+15.4%)
$2.54B(+4.5%)
Sep 2003
-
$612.30M(-3.6%)
$2.43B(+1.0%)
Jun 2003
-
$635.40M(+8.4%)
$2.41B(+1.9%)
Mar 2003
-
$586.20M(-2.0%)
$2.36B(+2.3%)
Dec 2002
$2.31B(+6.4%)
$598.30M(+1.8%)
$2.31B(+2.9%)
Sep 2002
-
$587.60M(-0.6%)
$2.25B(+1.3%)
Jun 2002
-
$591.30M(+11.1%)
$2.22B(+1.7%)
Mar 2002
-
$532.40M(-0.4%)
$2.18B(+0.3%)
Dec 2001
$2.17B(+4.5%)
$534.30M(-4.3%)
$2.17B(-0.3%)
Sep 2001
-
$558.40M(+0.9%)
$2.18B(+5.7%)
Jun 2001
-
$553.30M(+5.4%)
$2.06B(+5.9%)
Mar 2001
-
$525.00M(-3.1%)
$1.95B(+1.9%)
Dec 2000
$2.08B(+5.0%)
$541.80M(+22.7%)
$1.91B(-1.7%)
Sep 2000
-
$441.60M(+0.8%)
$1.94B(+2.1%)
Jun 2000
-
$438.10M(-10.4%)
$1.90B(+2.6%)
Mar 2000
-
$489.00M(-15.0%)
$1.86B(+7.2%)
Dec 1999
$1.98B(+9.1%)
$575.10M(+43.2%)
$1.73B(+9.4%)
Sep 1999
-
$401.60M(+3.0%)
$1.58B(+2.2%)
Jun 1999
-
$389.80M(+6.8%)
$1.55B(+2.8%)
Mar 1999
-
$364.90M(-14.4%)
$1.51B(+1.5%)
Dec 1998
$1.81B(+8.1%)
$426.40M(+16.0%)
$1.48B(+1.5%)
Sep 1998
-
$367.50M(+5.6%)
$1.46B(+2.3%)
Jun 1998
-
$347.90M(+1.6%)
$1.43B(+2.5%)
Mar 1998
-
$342.40M(-15.3%)
$1.39B(+2.6%)
Dec 1997
$1.68B(+7.4%)
$404.10M(+21.0%)
$1.36B(+0.3%)
Sep 1997
-
$334.10M(+6.6%)
$1.35B(+2.9%)
Jun 1997
-
$313.50M(+2.3%)
$1.32B(+2.6%)
Mar 1997
-
$306.50M(-23.4%)
$1.28B(+3.0%)
Dec 1996
$1.56B(+9.6%)
$400.10M(+35.3%)
$1.25B(+5.4%)
Sep 1996
-
$295.70M(+5.4%)
$1.18B(+5.0%)
Jun 1996
-
$280.50M(+4.1%)
$1.13B(+1.3%)
Mar 1996
-
$269.50M(-19.9%)
$1.11B(-1.3%)
Dec 1995
$1.43B(+11.0%)
$336.40M(+40.8%)
$1.13B(+2.3%)
Sep 1995
-
$238.90M(-10.1%)
$1.10B(-1.5%)
Jun 1995
-
$265.60M(-6.7%)
$1.12B(+3.1%)
Mar 1995
-
$284.60M(-8.6%)
$1.08B(+3.2%)
Dec 1994
$1.28B(+10.4%)
$311.30M(+21.7%)
$1.05B(+4.1%)
Sep 1994
-
$255.70M(+10.4%)
$1.01B(+3.0%)
Jun 1994
-
$231.60M(-7.7%)
$978.50M(+0.3%)
Mar 1994
-
$250.80M(-7.0%)
$975.60M(+2.2%)
Dec 1993
$1.16B(+17.4%)
$269.80M(+19.2%)
$954.30M(+2.5%)
Sep 1993
-
$226.30M(-1.0%)
$931.10M(-3.0%)
Jun 1993
-
$228.70M(-0.3%)
$959.70M(-2.5%)
Mar 1993
-
$229.50M(-6.9%)
$984.70M(-0.6%)
Dec 1992
$991.10M(+131.7%)
$246.60M(-3.3%)
$991.10M(+7.3%)
Sep 1992
-
$254.90M(+0.5%)
$923.30M(+76.3%)
Jun 1992
-
$253.70M(+7.5%)
$523.60M(+12.1%)
Mar 1992
-
$235.90M(+31.9%)
$467.10M(+9.2%)
Dec 1991
$427.80M(-37.2%)
$178.80M(-223.5%)
$427.80M(+5.6%)
Sep 1991
-
-$144.80M(-173.4%)
$405.20M(-44.4%)
Jun 1991
-
$197.20M(+0.3%)
$728.90M(+2.1%)
Mar 1991
-
$196.60M(+25.9%)
$713.60M(+4.8%)
Dec 1990
$680.90M(+27.9%)
$156.20M(-12.7%)
$681.00M(+8.6%)
Sep 1990
-
$178.90M(-1.6%)
$627.30M(+5.6%)
Jun 1990
-
$181.90M(+10.9%)
$593.80M(-65.1%)
Mar 1990
-
$164.00M(+60.0%)
$1.70B(-37.9%)
Dec 1989
$532.40M(+19.5%)
$102.50M(-29.5%)
$2.74B(-627.1%)
Sep 1989
-
$145.40M(-88.7%)
-$520.10M(-198.5%)
Jun 1989
-
$1.29B(+7.2%)
$528.10M(+24.3%)
Mar 1989
-
$1.20B(-138.1%)
$425.00M(+16.9%)
Dec 1988
$445.50M(-8.2%)
-$3.16B(-364.6%)
$363.50M(-231.7%)
Sep 1988
-
$1.19B(+0.6%)
-$276.10M(+632.4%)
Jun 1988
-
$1.19B(+3.9%)
-$37.70M(-117.7%)
Mar 1988
-
$1.14B(-130.1%)
$212.80M(-44.6%)
Dec 1987
$485.30M(+15.1%)
-$3.80B(-365.3%)
$383.90M(-50.8%)
Sep 1987
-
$1.43B(-0.4%)
$779.50M(+23.9%)
Jun 1987
-
$1.44B(+9.4%)
$629.10M(+43.4%)
Mar 1987
-
$1.31B(-138.6%)
$438.60M(+32.0%)
Dec 1986
$421.60M(+20.8%)
-$3.40B(-365.5%)
$332.30M(-47.8%)
Sep 1986
-
$1.28B(+2.8%)
$637.10M(+29.6%)
Jun 1986
-
$1.25B(+3.3%)
$491.40M(+34.0%)
Mar 1986
-
$1.21B(-139.0%)
$366.80M(+32.5%)
Dec 1985
$349.00M(-3.8%)
-$3.10B(-372.7%)
$276.80M(-592.5%)
Sep 1985
-
$1.14B(+1.2%)
-$56.20M(-685.4%)
Jun 1985
-
$1.12B(+0.5%)
$9.60M(-94.3%)
Mar 1985
-
$1.12B(-132.6%)
$167.70M(-43.2%)
Dec 1984
$362.80M
-$3.43B(-385.5%)
$295.20M(-92.1%)
Sep 1984
-
$1.20B(-6.1%)
$3.73B(+47.6%)
Jun 1984
-
$1.28B(+2.9%)
$2.52B(+102.9%)
Mar 1984
-
$1.24B
$1.24B

FAQ

  • What is Colgate-Palmolive annual EBITDA?
  • What is the all time high annual EBITDA for Colgate-Palmolive?
  • What is Colgate-Palmolive annual EBITDA year-on-year change?
  • What is Colgate-Palmolive quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Colgate-Palmolive?
  • What is Colgate-Palmolive quarterly EBITDA year-on-year change?
  • What is Colgate-Palmolive TTM EBITDA?
  • What is the all time high TTM EBITDA for Colgate-Palmolive?
  • What is Colgate-Palmolive TTM EBITDA year-on-year change?

What is Colgate-Palmolive annual EBITDA?

The current annual EBITDA of CL is $4.85B

What is the all time high annual EBITDA for Colgate-Palmolive?

Colgate-Palmolive all-time high annual EBITDA is $4.85B

What is Colgate-Palmolive annual EBITDA year-on-year change?

Over the past year, CL annual EBITDA has changed by +$607.00M (+14.30%)

What is Colgate-Palmolive quarterly EBITDA?

The current quarterly EBITDA of CL is $1.17B

What is the all time high quarterly EBITDA for Colgate-Palmolive?

Colgate-Palmolive all-time high quarterly EBITDA is $1.44B

What is Colgate-Palmolive quarterly EBITDA year-on-year change?

Over the past year, CL quarterly EBITDA has changed by -$23.00M (-1.93%)

What is Colgate-Palmolive TTM EBITDA?

The current TTM EBITDA of CL is $4.82B

What is the all time high TTM EBITDA for Colgate-Palmolive?

Colgate-Palmolive all-time high TTM EBITDA is $4.84B

What is Colgate-Palmolive TTM EBITDA year-on-year change?

Over the past year, CL TTM EBITDA has changed by +$423.00M (+9.62%)
On this page